Reduced angiopoietin-2 as a predictive biomarker for clomiphene citrate resistance in polycystic ovary syndrome

Reduced angiopoietin-2 as a predictive biomarker for clomiphene citrate resistance in polycystic ovary syndrome

Background: Even though angiopoeitin-2 and interleukin (IL)-23 are known to be altered in polycystic ovary syndrome (PCOS), their association with clomiphene citrate (CC) resistance has not been studied. Aim: The objective of the study was to investigate whether angiopoietin-2 levels are associated...

Full description

Bibliographic Details
Main Authors: Luxmipratha Rajendiran, Hanumanthappa Nandeesha, Thyagaraju Chitra
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2021-01-01
Series:Journal of Human Reproductive Sciences
Subjects:
angiopoietins
clomiphene citrate
interleukins
polycystic ovary syndrome
Online Access:http://www.jhrsonline.org/article.asp?issn=0974-1208;year=2021;volume=14;issue=2;spage=144;epage=148;aulast=Rajendiran

Internet

http://www.jhrsonline.org/article.asp?issn=0974-1208;year=2021;volume=14;issue=2;spage=144;epage=148;aulast=Rajendiran

Similar Items